GNR-069 therapy

GNR-069 · AO GENERIUM

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNR-069 therapy, covering 2024-06-21 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients [Phase 3]